(Q46715557)

24 December 2017

title

Efficacy of sildenafil in male dialysis patients with erectile dysfunction unresponsive to erythropoietin and/or testosterone treatments (English)

1 reference

24 December 2017

1 reference

1 reference

1 reference

Tas A

1

1 reference

24 December 2017

Ersoy A

2

1 reference

24 December 2017

Ersoy C

3

1 reference

24 December 2017

Gullulu M

4

1 reference

24 December 2017

Yurtkuran M

5

1 reference

24 December 2017

publication date

1 January 2006

1 reference

24 December 2017

International Journal of Impotence Research

published in

1 reference

24 December 2017

volume

18

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

61-68

1 reference

24 December 2017

Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

Association of decreased quality of life and erectile dysfunction in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

Erythropoietin and sexual dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

Efficacy and safety of sildenafil for treating erectile dysfunction in patients on dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

Preliminary observations of sildenafil treatment for erectile dysfunction in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

Effect of Erythropoietin on Sexual Potency In Chronic Haemodialysis Patients: A Preliminary Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

Efficacy and safety of sildenafil citrate in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

Efficacy of oral sildenafil in hemodialysis patients with erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

A novel therapy with testosterone and sildenafil for erectile dysfunction in patients on renal dialysis or after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

The pharmacokinetics and hemodynamics of sildenafil citrate in male hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

Sexual dysfunction in the male patient with uremia: A reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

7 January 2021

The epidemiology, anatomy, physiology, and treatment of erectile dysfunction in chronic renal failure patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

7 January 2021

Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

7 January 2021

Effect of maintenance hemodialysis on male sexual performance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

7 January 2021

Improved sexual function during recombinant human erythropoietin therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

7 January 2021

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

7 January 2021

Is erythropoietin effective for impotence in dialysis patients?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

7 January 2021

Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

7 January 2021

Effects of erythropoietin administration on prolactin secretion in normal subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

7 January 2021

Effects of long-term testosterone administration on pituitary-testicular axis in end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

7 January 2021

Timing of sildenafil therapy in dialysis patients-lessons following an episode of hypotension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901372

7 January 2021

Identifiers

DOI

10.1038/SJ.IJIR.3901372

1 reference

24 December 2017

1 reference

24 December 2017